Price comparison and purchasing suggestions of different generic versions of Tepotinib

Tepotinib is a targeted drug for patients with MET gene changes (especially MET exon 14 skipping mutations). It has been successfully launched in China and has been included in the medical insurance reimbursement system. Most of the drugs sold in the domestic market are original research drugs, and the price is relatively high, with a box costing about more than 30,000 yuan. Although reimbursement by medical insurance can reduce the burden on patients to a certain extent, for some patient families, financial pressure still exists. Therefore, price is always one of the key points that patients and their families pay attention to when choosing drugs.

In terms of generic versions of Tepotinib, there are many channels for purchasing generic Tepotinib in foreign markets, especially those from Laos. Lao pharmaceutical companies have invested heavily in the field of anti-cancer targeted drugs in recent years. Currently, generic drugs of Tepotinib produced by Lucius Pharmaceuticals and Daxiong Pharmaceuticals are common. Due to low production costs, the price of these generic drugs is significantly lower than that of domestic original drugs. Recently, it has even dropped to more than 6,000 yuan per box. Compared with the original drug's price of more than 30,000 yuan, the price gap is very obvious.

From the perspective of drug ingredients and mechanism of action, the Lao version of Tepotinib generic drug is basically the same as the original drug marketed in China in terms of main ingredients and efficacy mechanism, and can inhibit tumor growth for the same MET gene mutation patient group. Some clinical feedback also shows that generic drugs do not show significant differences in efficacy. However, it should be noted that generic drugs may differ from original drugs in terms of production processes, quality standards and regulatory requirements. Therefore, when choosing generic drugs, patients should give priority to manufacturers with higher reputations and strict quality control.

In terms of purchase suggestions, patients with better economic conditions and who hope to obtain the protection of the original drug can directly choose tepotinib, which is marketed in China, and reduce their financial burden through medical insurance reimbursement. For patients who are under great financial pressure or need to take medicine for a long time, they can consider the Lao version of generic drugs, but they must purchase them through formal and legal channels to avoid buying fake and shoddy products. At the same time, it is recommended that patients must do so under the guidance of their attending doctor before changing to a new version of the drug to ensure the efficacy and safety of the drug, and to achieve both affordability and therapeutic effect.

Reference link:https://www.drugs.com